Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to cancer treatment. Headquartered in San..
Praxis Precision Medicines, Inc (NASDAQ: PRAX), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its significant potential upside of 72.08%...
Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm specializing in addressing unmet medical needs, stands at a pivotal point in its market trajectory. The company, headquartered in..
Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the molecular diagnostics and precision medicine landscape, offers a diversified portfolio of genetic testing products. Despite its..
Owens & Minor, Inc. (OMI), a stalwart in the healthcare sector specializing in medical distribution, presents a compelling case for investors seeking potential upside in a..
Enhabit, Inc. (NASDAQ: EHAB) is steadily carving its niche in the medical care facilities sector of the healthcare industry, with a market capitalization standing at $568.75..
Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with a significant upside potential of 71.29% according to the latest analyst ratings. This clinical-stage..
EyePoint, Inc. (NASDAQ: EYPT) is capturing investor attention with a staggering potential upside of 177.35%, according to analyst ratings. Operating in the dynamic biotechnology sector within..
RxSight, Inc. (NASDAQ: RXST) is drawing attention in the healthcare sector, particularly in the medical devices industry, thanks to its innovative approach in cataract surgery solutions...
Maze Therapeutics, Inc. (NASDAQ: MAZE) has captured the attention of investors with its promising developments in the biotechnology sector. As a clinical-stage biopharmaceutical company, Maze focuses..
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing the attention of investors with its substantial potential upside of 114.62%, according to recent analyst ratings. As a clinical-stage..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a pioneering clinical-stage biopharmaceutical company, has captured the attention of investors with its promising drug pipeline and significant potential upside. As..
Replimune Group, Inc. (NASDAQ: REPL) is garnering attention in the biotechnology industry with its innovative approach to cancer treatment. As a clinical-stage company, Replimune is focused..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, presents an intriguing opportunity for investors seeking growth in the healthcare technology space...
Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) an intriguing prospect, given its focus on innovative gene and cell therapies...
Investors with a keen interest in the biotechnology sector should take note of Mind Medicine (MindMed) Inc. (MNMD), a company positioned at the forefront of developing..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) has recently caught the attention of investors with its promising pipeline in the biotechnology sector. As a clinical-stage biopharmaceutical company, ArriVent..
Beta Bionics, Inc. (BBNX), a prominent player in the healthcare sector, is emerging as a formidable force in the medical device industry. With a current market..
SIGA Technologies Inc. (NASDAQ: SIGA) might not be a household name in the vast landscape of healthcare, but this commercial-stage pharmaceutical company is making significant strides..
Investors seeking opportunities in the healthcare sector may want to turn their attention to Evolus, Inc. (NASDAQ: EOLS), a specialty and generic drug manufacturer that has..
